PhD Course: Innovation - from research to business in health sciences 2025

The PhD course trains young scientists in research commercialization through a series of inspirational and thematic talks combined with team exercises. Using scientific papers that have been the foundation of real spinouts, the teams will have to create an investor’s pitch to present and defend in front of a panel of investors their research commercialization plan using all the tools and knowledge they have gained during the course.

Enrolment deadline: October 17th, 2025
Read more and enroll: Graduate School of health and Medical Sciences (ku.dk)


Aim

The PhD course is aiming to train young scientists in research-based innovation through a series of inspirational and thematic talks combined with team exercises. Using scientific papers that have been the foundation of real spinouts, the teams will have to create an investor’s pitch to present and defend in front of a panel of investors their research commercialization plan using all the tools and knowledge they have gained during the course.

Content

Team creation, Ideation, Proof-of-Concept experiments, Market analysis, Business plan, Go-to-market Strategy, Intellectual property, Regulatory Affairs, Investments and funding, Company pitching.

Participants

The course is for PhD students at all levels with a natural interest and curiosity in innovation and research commercialization within the field of health and medical sciences, with a focus on therapeutics and medtech. The course does not require prior experience with innovation or research commercialization. Students with prior experience can, however, also benefit greatly from the course.

Speakers

(To be confirmed)

  • Trine Winterø, Vice Dean, Innovation and External Relations
  • Ulrik Krogh Andersen, CEO at Mequ
  • Bo Hjorth Bentzen, Assistant Professor, Department of Biomedical Sciences
  • Janine Terra Erler, Professor, BRIC
  • Ann Christine Korsgaard, Regulatory expert and Director at Ozack
  • Henriette Schultz Kirkegaard, Co-funder 3DIntegrated
  • Jørgen Søberg Petersen, Partner at Novo Holdings
  • Katja Kjær Grønbæk, CMO at WARD24/7
  • Kristian Strømgaard, Professor, Center for Biopharmaceuticals
  • Agnete Kirkeby, Associate Professor
  • Walden Bjørn-Yoshimoto, CEO at Akasi Pharma
  • Kamilla Rolsted, COO at Pepexia Therapeutics
  • Jakub Rubinowski, Business Developer at KU Lighthouse
  • Petar V. Todorov, Associate at BioInnovation Institute
  • Stephanie Munk, Investment Director at Sunstone Life Sciences Ventures
  • Umar Adegoke, Associate at BioInnovation Institute
  • Mandana Miri, Business Developer at KU Lighthouse

Register for the course

Enrollment deadline: October 17th, 2025
Read more and enroll: Graduate School of health and Medical Sciences (ku.dk)